Trademark Overview
On Wednesday, December 18, 2024, a trademark application was filed for EVRIFOR with the United States Patent and Trademark Office. The USPTO has given the EVRIFOR trademark a serial number of 98908984. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, January 14, 2025. This trademark is owned by ViiV Healthcare UK (No.3) Limited. The EVRIFOR trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases